Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tg Therapeutics, Inc.

Clinical trials sponsored by Tg Therapeutics, Inc., explained in plain language.

TG Therapeutics, Inc. TGTX NASDAQ

A biopharmaceutical company developing treatments for B-cell malignancies and autoimmune diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 2

15-Year safety check for experimental cell therapy

Knowledge-focused Not yet recruiting

This study tracks 32 people who received Azer-Cel, an experimental cell therapy for B-cell related autoimmune diseases, to monitor long-term safety for up to 15 years. Participants are checked for serious side effects and disease changes. The goal is to understand risks over time…

Sponsor: TG Therapeutics, Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:32 UTC